New SCMH Papers launched at ESC conference

Published: 28 September 2023

Journals released at European Society of Cardiology Conference in Amsterdam 2023

ESC Logo

Members of the School of Cardiovascular and Metabolic Health recently attended the European Society of Cardiology Conference in Amsterdam 2023. Please see a list of recent articles with the European Society of Cardiology: 

 

1: Leong DP, Joseph P, McMurray JJV, Rouleau J, Maggioni AP, Lanas F, Sharma SK, Núñez J, Mohan B, Celik A, Abdullakutty J, Ogah OS, Mielniczuk LM, Balasubramanian K, McCready T, Grinvalds A, Yusuf S, Joseph P; G-CHFInvestigators.

Frailty and outcomes in heart failure patients from high-, middle- and low-Income countries. Eur Heart J. 2023 Aug 28:ehad595. doi: 10.1093/eurheartj/ehad595. Epub ahead of print. PMID: 37639487.

 

2: Borlaug BA, Kitzman DW, Davies MJ, Rasmussen S, Barros E, Butler J, Einfeldt MN, Hovingh GK, Møller DV, Petrie MC, Shah SJ, Verma S, Abhayaratna W, Ahmed FZ, Chopra V, Ezekowitz J, Fu M, Ito H, Lelonek M, Melenovsky V, Núñez J, Perna E, Schou M, Senni M, van der Meer P, Von Lewinski D, Wolf D, Kosiborod MN.

Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial. Nat Med. 2023 Aug 27. doi: 10.1038/s41591-023-02526-x. Epub ahead of print. PMID: 37635157.

 

3: Chatur S, Vaduganathan M, Claggett BL, Mc Causland FR, Desai AS, Jhund PS, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez FA, Shah SJ, Sabatine MS, Kober L, Ponikowski P, Merkely B, Petersson M, Langkilde AM, McMurray JJV, Solomon SD.

Dapagliflozin in Patients with Heart Failure and Deterioration in Estimated Glomerular Filtration Rate to <25ml/min/1.73m<sup>2</sup>. J Am Coll Cardiol. 2023 Aug 23:S0735-1097(23)06532-4. doi: 10.1016/j.jacc.2023.08.026. Epub ahead of print. PMID: 37634707.

 

4: Butt JH, Lu H, Kondo T, Bachus E, de Boer RA, Inzucchi SE, Jhund PS, Kosiborod MN, Lam CSP, Martinez FA, Vaduganathan M, Solomon SD, McMurray JJV.

Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in HFmrEF/HFpEF: Insights from DELIVER. Eur J Heart Fail. 2023 Aug 26. doi: 10.1002/ejhf.3000. Epub ahead of print. PMID: 37634087.

 

5: Byrne RA, Fremes S, Capodanno D, Czerny M, Doenst T, Emberson JR, Falk V, Gaudino M, McMurray JJV, Mehran R, Milojevic M, Uva MS.

2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG. Eur J Cardiothorac Surg. 2023 Aug 1;64(2):ezad286. doi: 10.1093/ejcts/ezad286. PMID: 37632766.

 

6: Byrne RA, Fremes S, Capodanno D, Czerny M, Doenst T, Emberson JR, Falk V, Gaudino M, McMurray JJV, Mehran R, Milojevic M, Sousa Uva M.

2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG. Eur Heart J. 2023 Aug 26:ehad476. doi: 10.1093/eurheartj/ehad476. Epub ahead of print. PMID: 37632756.

 

7: Pabon M, Claggett BL, Wang X, Miao ZM, Chatur S, Bhatt AS, Vaduganathan M, Fang JC, Desai AS, Jhund P, Martinez F, De Boer RA, Kosiborod MN, Lam CS, Shah SJ, Hernandez AF, McMurray JJV, Solomon SD, Vardeny O.

Influence of background medical therapy on efficacy and safety of dapagliflozin in patients with heart failure with improved ejection fraction in the DELIVER trial. Eur J Heart Fail. 2023 Aug 26. doi: 10.1002/ejhf.3001. Epub ahead of print. PMID: 37632711.

 

8: Chatur S, Vaduganathan M, Claggett BL, Cunningham JW, Docherty KF, Desai AS, Jhund PS, De Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez FA, Shah SJ, Petersson M, Langkilde AM, McMurray JJV, Solomon SD.

Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial. Circulation. 2023 Aug 26. doi: 10.1161/CIRCULATIONAHA.123.066506. Epub ahead of print. PMID: 37632455.

 

9: Kosiborod MN, Abildstrøm SZ, Borlaug BA, Butler J, Rasmussen S, Davies M, Hovingh GK, Kitzman DW, Lindegaard ML, Møller DV, Shah SJ, Treppendahl MB, Verma S, Abhayaratna W, Ahmed FZ, Chopra V, Ezekowitz J, Fu M, Ito H, Lelonek M, Melenovsky V, Merkely B, Núñez J, Perna E, Schou M, Senni M, Sharma K, Van der Meer P, von Lewinski D, Wolf D, Petrie MC;

STEP-HFpEF Trial Committees and Investigators. Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity. N Engl J Med. 2023 Aug 25. doi: 10.1056/NEJMoa2306963. Epub ahead of print. PMID: 37622681.

 

10: McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Skibelund AK;

ESC Scientific Document Group. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023 Aug 25:ehad195. doi: 10.1093/eurheartj/ehad195. Epub ahead of print. PMID: 37622666.

 

11: Harrington J, Udell JA, Jones WS, Anker SD, Bhatt DL, Petrie MC, Andersen KR, Sumin M, Zwiener I, Hernandez AF, Butler J.

Baseline characteristics of patients enrolled in the EMPACT-MI trial. Eur J Heart Fail. 2023 Aug 25. doi: 10.1002/ejhf.2990. Epub ahead of print. PMID: 37622416.

 

12: Wang X, Jering KS, Cikes M, Tokmakova MP, Mehran R, Han Y, East C, Mody FV, Wang Y, Lewis EF, Claggett B, McMurray JJV, Granger CB, Pfeffer MA, Solomon SD.

Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE-MI. J Am Heart Assoc. 2023 Aug 23:e028942. doi: 10.1161/JAHA.122.028942. Epub ahead of print. PMID: 37609931.

 

13: Shingo Matsumoto, Toru Kondo, Pardeep S. Jhund, Ross T. Campbell, Karl Swedberg, Dirk J. van Veldhuisen, Stuart J. Pocock, Bertram Pitt, Faiez Zannad, and John J.V. McMurray

Underutilization of Mineralocorticoid Antagonists in Patients With Heart Failure With Reduced Ejection Fraction. J Am Coll Cardiol. Aug 27, 2023. Epublished DOI: 10.1016/j.jacc.2023.06.021


First published: 28 September 2023